Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Questions and Answers - Naloxone - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 145687
Later capture
Questions and Answers - Naloxone - Canada.ca
Jan 2, 2026
hc-20260101
ID 428758
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 2%
--- +++ @@ -27,5 +27,4 @@ It is important to note that P/Ts may differ in the way they follow NAPRA's NDS. Some automatically adopt NAPRA's NDS, while others may implement different conditions or restrictions than those recommended. These must be the same as, or more stringent than, the Prescription Drug List. For further information or detail about provincial or territorial differences on how to access naloxone in your region, contact your provincial or territorial Ministry of Health. Page details-Date modified: 2024-08-22